Prices for prescription drugs edged down by 1% last year, a rare result driven by declines for generics and slow, low growth in the cost of brand-name medications, the government said Thursday.
Dec 5, 2019
0
13
U.S. Medicare patients with multiple sclerosis often pay, on average, nearly $7,000 out of pocket to treat their condition each year. And, even though drug companies have provided no new treatment breakthroughs, the price ...
Nov 26, 2019
0
3
A pharmaceutical multinational on Thursday slashed the price of a key anti-tuberculosis drug boosting the battle against the world's deadliest infectious disease, as a new treatment was also set to begin extensive testing.
Oct 31, 2019
0
52
Drugmakers fought hard against California's groundbreaking drug price transparency law, passed in 2017. Now, state health officials have released their first report on the price hikes those drug companies sought to shield.
Oct 16, 2019
0
2
The price of a gram of methamphetamine has dropped to record lows in three North Island regions, while many South Island regions are also reporting substantial declines in prices for the drug.
Oct 10, 2019
0
2
Less than 5 percent of state drug pricing laws passed between 2015 and 2018 will provide new information about pricing within the pharmaceutical distribution system. The rest of the laws passed either do not focus on transparency ...
Oct 3, 2019
0
11
President Trump has called for ways to allow U.S. residents to buy cheaper prescription drugs from Canada. Many drugs are cheaper in Canada, thanks to government price controls in that country.
Oct 2, 2019
0
4
Demand for prescription medications in the U.S. is at an all time high, given that 50% of adults have at least one chronic condition, and 25% have two or more. Sixty percent of the population, and 90% of Medicare beneficiaries ...
Sep 11, 2019
0
2
Medicare often spends $3,590 for an individual's 30-day prescription after adjusting for all rebates, and prices continue to rise.
Sep 5, 2019
0
12
Over the course of a decade, out-of-pocket costs for multiple sclerosis drugs rose more than sevenfold for Medicare Part D beneficiaries, according to a JAMA Neurology study published today by researchers at the University ...
Aug 26, 2019
0
4
